ライフサイエンスコーパス: cessation

1 ch captures smoking duration, heaviness, and cessation).

2 reased risk of disease flare after treatment cessation.

3 allow prediction of outcome after treatment cessation.

4 effects disappeared soon after intervention cessation.

5 of recrudescing viremia following treatment cessation.

6 l drug targets for smoking prevention and/or cessation.

7 ses in fastigial output can underlie seizure cessation.

8 associated with more relapse after ribavirin cessation.

9 n, regular smoking, nicotine dependence, and cessation.

10 e a healthy lifestyle, in particular smoking cessation.

11 ty, BMD) is associated with subsistence task cessation.

12 rol residual leukemia levels after treatment cessation.

13 and functional deficits seen after treatment cessation.

14 ed to baseline within 6 weeks of PS training cessation.

15 ve to smoke and the subsequent difficulty in cessation.

16 with cigarette consumption and likelihood of cessation.

17 de a promising novel drug target for smoking cessation.

18 e) in preventing deterioration after steroid cessation.

19 ses had been quantified before and after TKI cessation.

20 a mean of 10 +/- 4 years following treatment cessation.

21 after premature (nonsterilizing) antibiotic cessation.

22 als remained elevated >5 years after smoking cessation.

23 s disease rebound after premature antibiotic cessation.

24 fforts to prevent smoking uptake and promote cessation.

25 ange in haemoglobin A1c (HbA1c), and smoking cessation.

26 fferent from never smokers 1-1.9 years after cessation.

27 of a rebound in platelet activity after drug cessation.

28 a major factor that interferes with smoking cessation.

29 ebound MS disease activity after natalizumab cessation.

30 ts that persisted for months after treatment cessation.

31 potential risk of using nicotine for tobacco cessation.

32 t either 30 min or 60 min following exercise cessation.

33 ly or to prevent viral rebound following ART cessation.

34 gic activation was achieved before treatment cessation.

35 ceived a leaflet with information on smoking cessation.

36 r smoking initiation and 13 loci for smoking cessation.

37 ergy by maintaining allergen tolerance after cessation.

38 post-injury, i.e. 1-2 months after treatment cessation.

39 Altered mood is a common reason for OC cessation.

40 tivation to stop smoking, quit attempts, and cessation.

41 was observed following maternal dolutegravir cessation (3-15 days postpartum), which waned with time

42 45% and 37% programs, respectively, require cessation 4 weeks prior to surgery.

43 was associated with a higher rate of insulin cessation (71.7%) than sleeve gastrectomy (SG; 64.5%; RR

44 ofessionals should be role models in tobacco cessation (75.3%), should provide smoking cessation supp

45 findings reinforce the importance of smoking cessation advice in preconception and antenatal care and

46 The smoking cessation agent varenicline, a partial agonist of alpha4

47 suggest e-cigarettes may not be an effective cessation aid for adult smokers and, instead, may contri

48 ctiveness and safety of cystine as a smoking cessation aid in patients with tuberculosis in Banglades

49 tes (e-cigarettes) are the preferred smoking-cessation aid in the United States; however, there is li

50 stration-approved antidepressant and smoking cessation aid, blocks dopamine and norepinephrine reupta

51 They were originally envisaged as a tobacco cessation aid, but whether or not they help people to qu

52 it with and without use of e-cigarettes as a cessation aid.

53 The limited number of smoking cessation aids currently available are minimally effecti

54 reported a past-year attempt to quit and the cessation aids used, and reported smoking status in 2016

55 ne and varenicline, two FDA-approved smoking cessation aids, during abstinence), on two well-establis

56 strates for the design of innovative smoking cessation aids.

57 = 622) was elevated in the first year after cessation (aIRR, 2.06 [95% CI, 1.42-2.99]) and declined

58 improving lung function and possibly smoking cessation, although larger, tissue-specific datasets are

59 ms of primary care interventions for tobacco cessation among school-aged children and adolescents who

60 patterns of dual antiplatelet therapy (DAPT) cessation and adverse events after percutaneous coronary

61 us, blood cholesterol, hypertension, smoking cessation and aspirin use.

62 rial chemoprevention protects long after its cessation and associates with effects on CD4(+) T cells.

63 n follow-up, particularly following exposure cessation and corticosteroid therapy, but the time cours

64 rt day (SD) treatment leads to apical growth cessation and dormancy.

65 in former smokers for decades after smoking cessation and in current smokers with low cumulative cig

66 terns, and association between modes of DAPT cessation and outcomes across bleeding risk groups.

67 The effect of time since cessation and pack years of smoking on biomarkers were i

68 ease was partially reversible upon treatment cessation and reinduced upon subsequent treatment.

69 inflammation may persist even after smoking cessation and responds variably to corticosteroids.

70 The analysis of TFS between ICI cessation and subsequent therapy initiation revealed lon

71 with CML determine their response to therapy cessation and that dose reductions can help to prospecti

72 with renal impairment, the time to bleeding cessation and the extent of hemostasis during procedures

73 returning B cell population after treatment cessation and the wider effects on other immune cells.

74 checkpoint inhibitor (ICI) protocol therapy cessation and time to subsequent systemic therapy initia

75 receive preventive measures such as smoking cessation and vaccination.

76 sted interventions improved rates of smoking cessation and weight loss, respectively.

77 ly, necessitates dose reduction or treatment cessation, and affects function and long-term quality of

78 multiple stages of tobacco use (initiation, cessation, and heaviness) as well as alcohol use, with 1

79 ance of smoking prevention and early smoking cessation, and indicate the need for public statements t

80 ons such as lowering blood pressure, smoking cessation, and lifestyle optimisation are common to all

81 8 wk, followed by a period of smoke exposure cessation, and the mice were immunized with the P6 lipop

82 viral response was sustained after treatment cessation, and these woodchucks also developed detectabl

83 behaviors, including amount smoked, smoking cessation, and tobacco-related diseases, are altered by

84 a on clinical algorithms to guide antibiotic cessation are limited.

85 Weight loss and smoking cessation are often useful.

86 maintained indefinitely, and the results of cessation are poorly understood.

87 ersons, but the clinical benefits of smoking cessation are unknown.

88 ge-specific productivity losses from hunting cessation associated with fracture and lower BMD are sub

89 e measure for the clinical study was insulin cessation at 1-year post-surgery: relative risks (RR) su

90 The primary endpoint was smoking cessation at 12 months ascertained via carbon monoxide m

91 ebound in As metabolite proportions after FA cessation; at wk 24, log(%InAs) and %DMAs were not signi

92 rofiling of individuals initiating a smoking-cessation attempt, we sought to characterize the kinetic

93 irometry decline in SZ-AATD, suggesting that cessation attenuates the obstructive process.

94 d reinforce preventive measures (eg, smoking cessation, blood pressure control, lipid management) and

95 reinforce preventive measures (e.g., smoking cessation, blood pressure control, lipid management) and

96 e of quitting at 6 months shows that smoking cessation can be achieved, but the waning of this effect

97 (n = 2183) was highest <1 year after smoking cessation compared to never smokers (aIRR, 1.66 [95% con

98 erral to cardiac rehabilitation, and smoking cessation counseling for patients with AMI.

99 Different AS cessation criteria had similar expected infection dynami

100 Primary outcome was tolerance of PPI cessation (discontinued or resumed PPIs).

101 at is controlled by low doses of the smoking cessation drug varenicline.

102 structive pulmonary disease (P = 0.043), the cessation duration before LTx (P < 0.001), and the packy

103 IRES are characterized by periods of flow cessation, during which channel substrates accumulate an

104 Deterring uptake of smoking and smoking cessation efforts should be prioritised to reduce future

105 care, pulmonology, health behavior, smoking cessation, epidemiology, and disparities research was co

106 , and MPO were mostly affected by time since cessation, especially if smoking currently or quit recen

107 ls of 119 genes were associated with smoking-cessation (FDR < 0.05, FC >=1.7) with a majority of the

108 ight loss and demographic variables, insulin cessation following surgery was comparable for RYGB and

109 miology and mechanisms in women; and tobacco cessation for people living with HIV.

110 below 10 parts per million and self-reported cessation for the past 7 days.

111 f mice with AT-RvD1 during a period of smoke-cessation further enhanced the efficacy of SPM-adjuvante

112 observed after a considerable period of drug cessation, generalized to learning about multiple aversi

113 Tobacco use initiation; tobacco use cessation; health outcomes; harms.

114 rdiovascular disease prevention (eg, smoking cessation, hypertension control, lipid management) and v

115 ed to determine the onset (hypothesis 1) and cessation (hypothesis 2) of radial growth and enable tra

116 efits of medication on likelihood of smoking cessation in 2 trials of bupropion at 26 weeks (n = 523;

117 cigarettes per day, pack-years, and smoking cessation in a fixed effects meta-analysis of up to 61 s

118 f 438 infants but did not lead to nevirapine cessation in any neonates; neutropenia (25 [6%] neonates

119 e viral rebound after antiretroviral-therapy cessation in assessing the results of cure-directed stra

120 nopy-level photosynthesis in spring, and its cessation in autumn.

121 the best strategies for facilitating smoking cessation in dental patients.

122 safety of varenicline versus NRT for smoking cessation in people with neurodevelopmental disorders, c

123 lterations in response to short-term smoking-cessation in the nasal epithelium.

124 ation and to determine the effect of smoking cessation in this genotype.Methods: We prospectively enr

125 al activity ('neural apnoea') accompanied by cessations in ventilation that result in moderate (but n

126 ing training and after 6 weeks from training cessation, in the femoral, popliteal (treated with stret

127 After treatment cessation, incomplete visual recovery was related to per

128 ion before LTx (P < 0.001), and the packyear-cessation index (PCI) (P < 0.001) were found to be signi

129 d the effectiveness of a video-based smoking cessation intervention focusing on maternal and child he

130 This smoking cessation intervention for expectant fathers that focuse

131 In the smoking cessation intervention for severe mental illness (SCIMIT

132 ined behavioural and pharmacological smoking cessation intervention targeted specifically at people w

133 ing (off PPIs for >=7 days) and a 3-week PPI cessation intervention.

134 [HR] 5.03, 4.98 to 5.08, P < 0.001), smoking cessation interventions (HR 3.20, 3.13 to 3.27, P < 0.00

135 obacco control and expect to receive smoking cessation interventions during their hospital stay.

136 es, yet there is a lack of effective smoking cessation interventions targeted at expectant fathers.

137 Pharmacological tobacco cessation interventions were found to have a comparable

138 cacy, and outcomes of posttransplant tobacco cessation interventions.

139 had higher expectations of receiving smoking cessation interventions.

140 Smoking cessation is especially important for people who are mor

141 Smoking cessation is important in patients with tuberculosis bec

142 h to identify candidates appropriate for PPI cessation is not available.

143 diovascular disease (CVD) risk after smoking cessation is unclear.

144 ing cessation.SIGNIFICANCE STATEMENT Smoking cessation leads the occurrence of physical and affective

145 th PD-1 blockade at the time of chemotherapy cessation may be attractive for mechanistic and pragmati

146 ice of Food and Drug Administration-approved cessation medication (nicotine replacement therapy, bupr

147 , sustained counseling and provision of free cessation medication compared with 4-week counseling and

148 dard treatment participants (59.1%) reported cessation medication use (difference, 17.9% [95% CI, 6.3

149 of gene-expression alterations upon smoking-cessation might delineate distinct biological processes

150 immunosuppressive agents as well as smoking cessation might prevent conversion to GMG.

151 ng risk status and clinical outcomes for any cessation mode.

152 icotine, including nicotine found in smoking-cessation nicotine-replacement therapies, may have poten

153 smokers, although this was not the case when cessation occurred in the first or second trimester of p

154 stained regulatory T-cell response, after IT cessation, occurs in two-thirds of the patients.

155 Despite cessation of adjunct treatments, Group 1 and 2 continued

156 nence following punishment imposed voluntary cessation of alcohol use.

157 ribute to ciliary disassembly in response to cessation of anterograde IFT: a slow shortening that is

158 life and may lead to dose reduction or even cessation of anti-tumor therapy.

159 Our study provides support for the cessation of antibiotic prophylaxis in the moderate-risk

160 VRC01 infusions affected viral rebound after cessation of antiretroviral therapy (ART) in 18 acutely

161 ndividuals who are able to control HIV after cessation of antiretroviral therapy, but characteristics

162 and likely contributes to viral rebound upon cessation of antiretroviral therapy.

163 voir that gives rise to rebound viremia upon cessation of ART.

164 anges induced by stochastic responses to the cessation of biological functions.

165 Time to cessation of bleeding and the proportion with normal hem

166 Clinical success was defined as cessation of bleeding as determined by hemodynamic stabi

167 thout toxicity by a third end point, time to cessation of both ICI therapy and toxicity.

168 death (DCD) can be defined by the permanent cessation of brain circulation.

169 the donor's body may interrupt the permanent cessation of brain perfusion because, theoretically, col

170 rtant determinant of microbiota composition; cessation of breastfeeding, rather than solid food intro

171 and streptococci significantly decreased on cessation of breastfeeding, whereas bacteria within the

172 ient showed recurrence of inflammation after cessation of brimonidine.

173 ghts into how cancer risk persists following cessation of carcinogenic exposures.

174 fficiently suppress HIV replication, but the cessation of cART usually results in viral rebound, most

175 Yet cessation of chronic hypoxia promoted lung cell apoptosi

176 ral reports of habitat destruction following cessation of conflict, there has never been a systematic

177 ovel effect of ketamine, namely the complete cessation of cortical EEG activity.

178 memory T cells during effective therapy, and cessation of current treatments results in resumption of

179 After cessation of D-amphetamine treatment, the motivation to

180 Following the cessation of discharge, abundances of fishes mostly retu

181 t times during, and four times following the cessation of discharging hypersaline brine, we sampled r

182 sic temporal patterning program that ensures cessation of divisions before adulthood.

183 e-dependent increase in heroin seeking after cessation of drug self-administration (incubation of cra

184 ime-dependent increase in drug seeking after cessation of drug self-administration).

185 gery is the most common reason for premature cessation of dual antiplatelet therapy.

186 otropic incompetence might reflect premature cessation of exercise before maximal sinus node activati

187 prototypical high-fat diet (HFD) as well as cessation of exposure on phenotype reversibility.

188 able epigenetic control mechanisms following cessation of exposure.

189 milar pattern of platelet recovery following cessation of extracorporeal membrane oxygenation.

190 third-phase formation is consistent with the cessation of extraction (at the loading limit).

191 IIS, but translocates to the cytoplasm upon cessation of feeding in the third instar stage.

192 was given as '0.99, 95% CI: 0.90-1.08', the cessation of flowering slope was given as '1.02, 95% CI:

193 Cessation of glaucoma medications results in a dose-depe

194 ound 1450 ce could also have accelerated the cessation of grazing pressure, particularly in the Pyren

195 at of nutrient deprivation, concomitant with cessation of growth and depletion of chloroplasts.

196 diness in overwintering conifers, leading to cessation of growth, bud dormancy, freezing tolerance an

197 Fracture is associated with cessation of hunting, tree chopping, and walking long di

198 role in strengthening mechanisms underlying cessation of ictal propagation should inspire new ration

199 the tissue-resident memory T-cell pool after cessation of IL-10 production.

200 During follow-up visits 2 and 3 years after cessation of immunosuppression, the patient exhibited no

201 of true operational tolerance after complete cessation of immunosuppression.

202 ying the sustained response after 2 years of cessation of immunotherapy (3-year treatment period) are

203 climatic change coincides with a shelf-wide cessation of inorganic aragonite production and a switch

204 associated with high rates of postoperative cessation of insulin therapy, which is, in turn, a major

205 y depleting their own reserves and prompting cessation of lactation.

206 The national transplant system saw near cessation of living donor transplantation (-90%) from th

207 mal system operated for ~150 years after the cessation of magma flow.

208 Following cessation of monotherapy with PARP or WEE1 inhibitors, e

209 udy with monovalent Sabin OPV2 before global cessation of monovalent OPV2 use, and a phase 2 study wi

210 cal relapse and hepatic decompensation after cessation of NA was explored.

211 ependent increase in oxycodone seeking after cessation of opioid self-administration (incubation of o

212 n of peptidoglycan synthesis at mid-cell and cessation of polar peptidoglycan biosynthesis.

213 dle assembly, leading to mitotic failure and cessation of proliferation.

214 horns, these stem cells undergo a programmed cessation of proliferative activity.

215 alized rates of bleeding events and complete cessation of prophylactic factor VIII use in all partici

216 ncreased risk of liver-related disease after cessation of prophylactic NA therapy in patients who rec

217 sonal decline of photosynthetic activity and cessation of radial tree growth was not significantly di

218 e statistics to determine factors predicting cessation of SE within 1 hour (for generalized convulsiv

219 This underdosing correlated with lack of cessation of SE.

220 Our findings support that treating VRF and cessation of smoking may be important in the management

221 ality fell by more than 60% in 5 years after cessation of solid fuel use and continued to decrease af

222 ociated with a higher risk of mortality, and cessation of solid fuel use cuts excess mortality risks

223 postural adjustments (APAs), resulting in a cessation of step initiation due to supraspinal dysfunct

224 Cessation of stimulation resulted in significant enhance

225 was maintained for several months after the cessation of stimulation, illustrating long-term benefit

226 exhibiting attenuation and responses to the cessation of stimulation, which are signatures of respon

227 ncrease in anxiety and anhedonia after acute cessation of stimulation.

228 ly lower RNA levels up to 6 months after the cessation of study drug.

229 improvement in his pulmonary function tests, cessation of supplemental oxygen requirements and near n

230 These changes were accompanied by cessation of TBI-induced chronic axonal degeneration.

231 pared the long-term efficacy after treatment cessation of the combination of venetoclax plus obinutuz

232 t of sufficient population immunity to drive cessation of the coronavirus disease of 2019 (COVID-19)

233 d tissue macrophages that perdure long after cessation of the treatment.

234 l, intact HIV RNA populations in blood after cessation of therapy, which repopulated tissues througho

235 f the microbiome was reestablished following cessation of therapy.

236 Few trials addressed prevention or cessation of tobacco products other than cigarettes; no

237 primary care-feasible interventions for the cessation of tobacco use among school-aged children and

238 ith oral metronidazole and were evaluated at cessation of treatment and monthly.

239 nce of autoimmune memory in vitiligo because cessation of treatment frequently led to relapse of dise

240 stasis during the treatment period and upon cessation of treatment, tumours re-grew.

241 prior to randomization and 1 month following cessation of treatment/waiting list.

242 ammatory angiogenesis persists following the cessation of ultraviolet light exposures and accurately

243 ed them through up to 2 months following the cessation of UV exposure, observing a progressive increa

244 All patients recovered with cessation of vaping, supportive care, and steroid therap

245 regulated in response to PM2.5 exposure, the cessation of which was associated with a reversal of ins

246 on shows that the genetic effects of smoking cessation on body weight vary from different populations

247 stry data to determine the effect of smoking cessation on spirometry decline (n = 60) and plasma anti

248 ive smoking exposure and duration of smoking cessation on the recurrence of periodontitis.

249 ances which surround the viral outbreak, the cessation or a reduction in LT activity is a pragmatic r

250 eral tolerance mechanisms initiated by early cessation or diminution of thymic output.

251 romoting healthier behaviors such as smoking cessation or in aiding persons with a family history of

252 P nAChRs, either volitionally during smoking cessation or inadvertently via receptor desensitization

253 ties, but there was no difference in tobacco cessation or medication adherence between the treatment

254 chanisms of translation, including premature cessation or reinitiation of translation, and read-throu

255 cioeconomic position, did not report smoking cessation outcomes from 6 months or longer after the sta

256 necessary to achieve equity-positive smoking cessation outcomes.

257 nt consists primarily of alcohol and smoking cessation, pain control, replacement of pancreatic insuf

258 Cessation, particularly before age 40 years, yields larg

259 After antibiotic cessation, patients had an abrupt shift in microbiome co

260 Some behavioural interventions (eg, smoking cessation programmes), although beneficial overall, can

261 meaningfully decreased death risk; however, cessation provided a larger benefit than even large decl

262 s counseling and pharmacotherapy for smoking cessation, pulmonary rehabilitation, treatment of comorb

263 7, CI 0.90-1.04), with AGB having the lowest cessation rates (RR 0.55, CI 0.40-0.74; p < 0.001).

264 tronic cigarettes (e-cigarettes) for smoking cessation remain controversial.

265 ich took place 1 and 2 years after treatment cessation, respectively.

266 Systematically providing smoking cessation services in hospitals may have a relevant impa

267 cipants were offered access to local smoking cessation services not specifically designed for people

268 e, referral to weight management and smoking cessation services.

269 s have not historically engaged with smoking cessation services.

270 Interventions for smoking prevention or cessation should be implemented in these high risk popul

271 l and neurochemical homeostasis after stress cessation.SIGNIFICANCE STATEMENT Chronic psychosocial st

272 ay offer an interesting strategy for smoking cessation.SIGNIFICANCE STATEMENT Smoking cessation leads

273 imary care after discussion with the smoking cessation specialist.

274 Smoking cessation strategies should be implemented, especially i

275 Before and 1 week after treatment cessation, study participants underwent MRI, including D

276 co cessation (75.3%), should provide smoking cessation support to patients (83.0%), and that hospital

277 e and not smoke" and "should provide smoking cessation support"; (ii) hospitals "should provide smoki

278 se, as well as assists in optimizing smoking cessation support, which in turn will reduce the enormou

279 h erlotinib versus erlotinib after treatment cessation supports that the combination reduces cell sur

280 Following drug cessation, TFV concentrations persisted longer in urine

281 uronal activity during CS onset and freezing cessation; these neural correlates were abolished by che

282 ) have been proposed as an effective smoking cessation tool.

283 ort"; (ii) hospitals "should provide smoking cessation treatments" and are "role model organizations

284 hat of nicotine products approved as smoking-cessation treatments.

285 2 years after treatment cessation, venetoclax plus obinutuzumab continues to sig

286 Seizure cessation was achieved at multiple stimulation frequenci

287 treatment and regrowth rate after treatment cessation was associated with phospho-S6/total S6 expres

288 When the time since cessation was considered, the area-under-the-curve value

289 Recombination cessation was found associated with a large inversion in

290 The cumulative incidence of DAPT cessation was higher in HBR patients, mostly driven by p

291 admitted to general hospitals where smoking cessation was not given as part of their portfolio, with

292 ls with diverse expertise related to smoking cessation were empaneled to prioritize questions and out

293 Modes of DAPT cessations were defined as physician-guided DAPT discont

294 vioral interventions and controls in smoking cessation when trials were restricted to smokers (9 tria

295 aining baseline within 6 weeks from training cessation, whereas those more related to a local mechani

296 erm association of cigarette smoking and its cessation with the incidence of the 3 outcomes.

297 meters (pack-years, duration, intensity, and cessation) with incident PAD were quantified and contras

298 Bleeding cessation within 24 hours was reported in 92 of 134 eval

299 d to the study drug; each resolved upon drug cessation without sequelae.

300 ) has shown preliminary efficacy for smoking cessation, yet its neurobiological target remains unknow